Stay updated on SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Recruitment status has been updated to no longer look for participants, indicating the study is not enrolling currently. The page also adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) and makes a minor typographic adjustment to the Intervention/Treatment label alongside updating the page revision tag to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T13:34:34.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page update adds Revision: v3.5.5 and removes Revision: v3.5.4, indicating a small backend or template update. This change reflects an updated versioning tag used for the site's rendering of the study details.
    Difference
    0.1%
    Check dated 2026-06-05T08:25:23.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Introduction of a new Informed Consent Form (PDF, 0.31MB) and related study documents, provided by Washington University School of Medicine. These materials are listed under revision 3.5.4, replacing the previous 3.5.3 version.
    Difference
    0.8%
    Check dated 2026-05-15T04:46:47.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.2 to v3.5.3, indicating a newer version of the study record. This reflects a minor administrative update that does not change the study content or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-04-30T18:54:05.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision note updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:28:04.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Updated the follow-up time frame for several outcomes. The period from 91 days through completion of follow-up (estimated 24 months) was replaced with 91 days through 12 months post-SBRT or 90 days after the last defactinib dose, whichever comes first (estimated 12 months 5 days).
    Difference
    0.3%
    Check dated 2026-03-26T02:32:51.000Z thumbnail image

Stay in the know with updates to SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT and FAK Inhibitor in Advanced Pancreas Adenocarcinoma Clinical Trial page.